A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A. | stellaPhase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
Trial locations(7 sites)
United States
Orthopaedic Institute for Children/Orthopaedic Hemophilia Treatment Center, Los Angeles, California Brody School of Medicine at East Carolina University, Greenville, North Carolina ECU Health Medical Center, Greenville, North Carolina India
Nirmal Hospital Pvt Ltd., Surat, Gujarat K J Somaiya Hospital & Research Centre, Mumbai, Maharashtra